Über einige unsymmetrische Disulfide

Runge, Franz; Jumar, Alfred; Held, P.

doi:10.1002/prac.19590080106

Cited by 8 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MeCN and CH 2 Cl 2 were distilled under N 2 from CaH 2 , while THF, from sodium/benzophenone ketyl. 2-TsOCH 2 -6-PMBOC 5 H 3 N (PMB = 4-MeOC 6 H 4 CH 2 ), Benzoyl persulfide, thiobenzoyl persulfide, 2,2′-dithio-6,6′-dimethylpyridine, 2-TsOCH 2 -6-HOCH 2 C 5 H 3 N (Ts = 4-MeC 6 H 4 SO 2 ), 2-ClCO-6-RC 5 H 3 N (R = MeO, PhS), and Na 2 Fe(CO) 4 ·1.5(1,4-dioxane), were prepared according to the published methods. Benzoyl peroxide and other materials were available commercially and used as received.…”

Section: Experimental Sectionmentioning

confidence: 99%

Several New [Fe]Hydrogenase Model Complexes with a Single Fe Center Ligated to an Acylmethyl(hydroxymethyl)pyridine or Acylmethyl(hydroxy)pyridine Ligand

Song

Zhao

et al. 2014

Organometallics

View full text Add to dashboard Cite

We have developed two novel synthetic methods, by which two types of mononuclear Fe model complexes for the active site of [Fe]hydrogenase are successfully synthesized. The first type of 2-acylmethyl-6-hydroxymethylpyridine-containing complexes, [2-COCH 2 -6-HOCH 2 C 5 H 3 N]Fe(CO) 2 G (1, G = PhCO 2 ; 2, PhCOS; 3, PhCS 2 ; 4, 2-S-6-MeC 5 H 3 N), were prepared by a "one-pot" method involving reaction of 2-TsO-6-HOCH 2 C 5 H 3 N (Ts = 4-MeC 6 H 4 SO 2 ) with Na 2 Fe(CO) 4 followed by treatment of the resulting Fe(0) intermediate [Na(2-CH 2 -6-HOCH 2 C 5 H 3 N)Fe(CO) 4 ] (M1) with (PhCO 2 ) 2 , (PhCOS) 2 , (PhCS 2 ) 2 , and (2-S-6-MeC 5 H 3 N) 2 in 49−72% yields, respectively. The second type of 2-acylmethyl-6-hydroxypyridine-containing complexes, (2-COCH 2 -6-HOC 5 H 3 N)Fe(CO) 2 (2-SCO-6-RC 5 H 3 N) (9a, R = MeO; 9b, R = PhS), could be prepared via a multiple-step synthetic method. This method involves (i) treatment of 2-ClCO-6-RC 5 H 3 N (R = MeO, PhS) with NaSH followed by acidification with diluted HCl to give 2-HSCO-6-RC 5 H 3 N (5a, R = MeO; 5b, R = PhS); (ii) further treatment of 5a,b with KOH to afford 2-KSCO-6-RC 5 H 3 N (6a, R = MeO; 6b, R = PhS); (iii) treatment of 2-TsOCH 2 -6-PMBOC 5 H 3 N (PMB = 4-MeOC 6 H 4 CH 2 ) with Na 2 Fe(CO) 4 followed by treatment of the resulting Fe(0) intermediate [Na(2-CH 2 -6-PMBOC 5 H 3 N)Fe(CO) 4 ] (M2) with Br 2 or I 2 to produce (2-COCH 2 -6-PMBOC 5 H 3 N)Fe(CO) 3 X (7a, X = Br; 7b, X = I); (iv) further treatment of 7a,b with 6a,b to yield (2-COCH 2 -6-PMBOC 5 H 3 N)Fe(CO) 2 (2-S-6-RC 5 H 3 N) (8a, R = MeO; 8b, R = PhS); and (v) finally, removal of the PMB groups from 8a,b under the action of deprotecting reagent CF 3 CO 2 H/EtSH to give complexes 9a,b. All compounds 1−4 and 5a,b−9a,b with the exception of 7b are new and have been characterized by elemental analysis, spectroscopy, and, particularly for 1, 4, and 7a−9a, X-ray crystallography.

show abstract